Picked this up off of the VLA forum ... all I can say is, "Walk this way..."
Quote:
The global clinical development expert said Merck was trying to find great drugs and was relatively agnostic as to whether those drugs were in a specific area.
“Great drugs will build great businesses. The goal is to find important drugs that address serious medical conditions and if developed well can change the human experience. That is the goal, it’s less about focusing on an area, we really want to focus on great drugs and great biology.”
Dr Baynes said the company looked at hundreds of companies each year, adding that he liked to think that Merck had a good idea of what was going on in most companies around the world.
“We have a group whose job it is to understand what others are working on and what the discovery output looks like. If we find a company that presents to us as attractive, we will often put them on a watch list,” he said.
Worth a look: Merck has keen eye on Australian R&D
Add to My Watchlist
What is My Watchlist?
